Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 173 publications
Non-Muscle Invasive Recurrence and Management During Surveillance in Patients with Muscle-Invasive Bladder Cancer Who Achieve Clinical Complete Response to Neoadjuvant Chemotherapy.
Journal: The Journal of urology
Published: August 26, 2026
A Phase 2 Trial of Intravesical Cabazitaxel, Gemcitabine, and Cisplatin (CGC) for the Treatment of Non-Muscle Invasive BCG Unresponsive Urothelial Carcinoma of the Bladder.
Journal: The Journal of urology
Published: July 17, 2026
The Academic Relative Value Unit: How to Quantify and Reward Nonclinical Efforts?
Journal: Urology practice
Published: May 27, 2025
Active Surveillance vs Primary Intervention for Clinical T1a Kidney Tumors: 12-Year Experience of the Delayed Intervention and Surveillance for Small Renal Masses Prospective Comparative Study.
Journal: The Journal of urology
Published: April 22, 2025
Neoadjuvant Fc-enhanced anti-CTLA-4 targets Tregs to augment androgen deprivation in high-risk prostate cancer: A randomized phase I trial.
Journal: Cell reports. Medicine
Published: April 14, 2025
Management of Patients with Muscle-Invasive Bladder Cancer Achieving A Clinical Complete Response after Neoadjuvant Therapy: Evidence and Consideration for Active Surveillance.
Journal: Current urology reports
Published: March 27, 2025
Tumour size is associated with growth rates of >0.5 cm/year and delayed intervention in small renal masses in patients on active surveillance.
Journal: BJU international
Published: January 28, 2025
Combination regimen of intravesical docetaxel, gemcitabine, and cisplatin in patients with BCG-unresponsive bladder cancer: clinical outcomes and genomic correlations.
Journal: Urologic oncology
Published: January 20, 2025
Fc-enhanced anti-CTLA-4 depletes tumor-infiltrating regulatory T cells to augment immune effects of androgen ablation in high-risk prostate cancer.
Journal: medRxiv : the preprint server for health sciences
Published: September 24, 2024
Last Updated: 09/26/2026